Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters

Oxidation of carbamazepine by Mn(VII) and Fe(VI): reaction kinetics and mechanism

Experimental studies were conducted to examine the oxidation of carbamazepine, an anticonvulsant drug widely detected in surface waters and sewage treatment effluent, by potassium salts of permanganate (Mn(VII); KMnO4) and ferrate (Fe(VI); K2FeO4). Results show that both Mn(VII) and Fe(VI) rapidly oxidize carbamazepine by electrophilic attack at an olefinic group in the central heterocyclic ring, leading to ring-opening and a series of organic oxidation products. Reaction kinetics follow a generalized second-order rate law, with apparent rate constants at pH 7.0 and 25 degrees C of 3.0 (+/-0.3) x 10(2) M(-1) s(-1) for Mn(VII) and 70(+/-3) M(-1) s(-1) for Fe(VI). Mn(VII) reaction rates exhibit no pH dependence, whereas Fe(VI) reaction rates increase dramatically with decreasing pH, due to changing acid-base speciation of Fe(VI). Further studies with Mn(VII) show that most common nontarget water constituents, including natural organic matter, have no significant effect on rates of carbamazepine oxidation; reduced metals and (bi)sulfide exert a stoichiometric Mn(VII) demand that can be incorporated into the kinetic model. The removal of carbamazepine in two utility source waters treated with KMnO4 agrees closely with predictions from the kinetic model that was parametrized using experiments conducted in deionized water at much higher reagent concentrations.

Assessing the discharge of pharmaceuticals along the Dutch coast of the North Sea

This chapter assessed the annual median discharge of over 100 pharmaceuticals to the DCZ. Calculations were based on pharmaceutical concentrations in surface-, sewage-, and industrial water in the Netherlands. In 2002, riverine discharge to the DCZ for individual pharmaceuticals varied from 0 (concentration below LOD) to 27 t yr(-1). However, in 2002 the annual amount was less than 2 t for 75% of the studied pharmaceuticals. The highest loads were calculated for X-ray contrast media, that is, values of 18-27 t yr(-1) for iopromide. The top 20 pharmaceuticals discharged by rivers to the DCZ are dominated by X-ray contrast media (n = 7), followed by antibiotics (n = 6), analgesics/antipyretics/anti-inflammatory drugs (n = 2), beta blockers (n = 2), fibrates/lipid regulators (n = 1), veterinary antibiotics (n = 1), and others (n = 1). The direct discharge (sewage water and industrial water) of pharmaceuticals to the DCZ, in 2002, for individual pharmaceuticals varied from < 0.0009 to 0.27 t yr(-1) for sewage water, and from < 0.0009 to 0.33 t yr(-1) for industrial wastewater. The highest loads were calculated for sotalol (beta blocker) and diatrizoic acid (X-ray contrast medium) in sewage water and industrial wastewater, respectively. The direct discharge of pharmaceuticals to the DCZ is < 5% of that from riverine discharge. The discharge of these pharmaceuticals to the DCZ in 2002 is in the same order of magnitude as the discharge rates of the mandatory OSPAR substances Cd (8.8-10 t yr(-1)) and Hg (3.3 t yr(-1)), and are higher than the discharge rates of the mandatory substance lindane (0.041-0.055 t yr(-1)) and the recommended substance PCBs (0.217 t yr(-1)). Although some pharmaceuticals are discharged in significant amounts to the DCZ, the human and ecotoxicological risks of these highly biologically active compounds are largely unknown. To determine the environmental hazard and risk of discharged pharmaceuticals to the marine environment, future research should focus on a baseline study and a risk assessment of the discharged pharmaceuticals in the DCZ.

Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review

Pharmaceuticals and personal care products (PPCPs) have been the focus of much recent research as concerns rise about their occurrence in bodies of water worldwide. In an effort to characterize the risk and determine the prevalence of these micropollutants in lakes and rivers, many researchers are examining PPCP removal from impaired water during wastewater treatment and water recycling (soil passage) processes. Biodegradation studies and projects considering combinations of biodegradation and other removal processes have been conducted over a wide range of compound categories and therapeutic classes, as well as across different systems and scales of study. This review summarizes the extent of PPCP removal observed in these various systems.

Wastewater-contaminated groundwater as a source of endogenous hormones and pharmaceuticals to surface water ecosystems

Increasing residential development in watershed recharge areas increases the likelihood of groundwater and surface water contamination by wastewater effluent, particularly where on-site sewage treatment is employed. This effluent contains a range of compounds including those that have been demonstrated to mimic or interfere with the function of natural hormones in aquatic organisms and humans. To explore whether groundwater contaminated by discharge from on-site septic systems affects water quality in surface water ecosystems, we measured steroidal hormones, pharmaceuticals, and other organic wastewater compounds (OWCs) in water collected from six aquifer-fed ponds in areas of higher and lower residential density on Cape Cod (Massachusetts, USA). We detected both a greater number and higher concentrations of OWCs in samples collected from ponds located in higher residential density areas. Most often detected were the steroidal hormones androstenedione, estrone, and progesterone and the pharmaceuticals carbamazepine, pentoxifylline, sulfamethoxazole, and trimethoprim. Of particular concern, estrogenic hormones were present at concentrations approaching those that induce physiological responses in fish. While a number of papers have reported on surface water contamination by OWCs from wastewater treatment plants, our results show that surface water ecosystems in unconfined aquifer settings are susceptible to contamination by estrogenic and other biologically active OWCs through recharge from aquifers contaminated by residential septic systems.

Sorption and mobility of pharmaceutical compounds in soil irrigated with reclaimed wastewater

Use of reclaimed wastewater for irrigation is an important route for the introduction of pharmaceutical compounds (PCs) into the environment. In this study, the mobility and sorption-desorption behavior of carbamazepine, naproxen and diclofenac were studied in soil layers sampled from a plot irrigated with secondary-treated wastewater (STWW). Carbamazepine and diclofenac were significantly retarded in the 0-5 cm soil sample rich in soil organic matter (SOM): carbamazepine was not affected by the water quality (freshwater versus STWW), whereas diclofenac exhibited a higher retardation factor (RF) in the freshwater system. Naproxen exhibited significantly lower RFs than diclofenac but with a similar trend - higher retardation in the freshwater versus STWW system. In the 5-15 cm soil sample containing low SOM, naproxen was highly mobile while carbamazepine and diclofenac were still retarded. In the 15-25 cm sample, all compounds exhibited their lowest RFs. Sorption data suggested that SOM governs the studied PCs' interactions with the soil samples. However, higher carbon-normalized sorption coefficients were measured for the PCs in the 15-25 cm sample, suggesting that both quantity and the physicochemical nature of SOM affect sorption interactions. While both naproxen and carbamazepine exhibited reversible sorption isotherms, diclofenac exhibited pronounced sorption-desorption hysteresis. This study suggests that carbamazepine and diclofenac can be classified as slow-mobile compounds in SOM-rich soil layers. When these compounds pass this layer and/or introduced into SOM-poor soils, their mobility increases significantly. This emphasizes the potential transport of PCs to groundwater in semiarid zones due to intensive irrigation with reclaimed wastewater in SOM-poor soils.

Occurrence of diclofenac and selected metabolites in sewage effluents

Many pharmaceuticals along with their metabolites have been detected in environmental water samples in the recent decades. The analgesic diclofenac is widely used and thus enters the aquatic environment. Already at realistic environmental concentration levels harmful effects to different organisms have been demonstrated. As this could also be expected for its metabolites, their fate was examined. Six wastewater treatment plant effluents collected throughout Germany were analyzed for the drug and two of its hydroxylated metabolites, 4'-hydroxy diclofenac (4'-OHD) and 5-hydroxy diclofenac (5-OHD), together with the lactam of 4'-OHD, 4'-hydroxy diclofenac dehydrate (4'-OHDD). A quantitative analytical method has been developed using solid-phase extraction followed by LC-ESI-MS/MS. The limits of quantitation (LOQ) in sewage effluent were 0.06 mug/l for diclofenac and its hydroxyl metabolites and 0.07 microg/l for 4'-OHDD. Recoveries ranged from 62 to 81%. The metabolites were detected in the samples in median concentration ranges of <LOQ to 0.71 microg/l, <LOQ to 0.45 microg/l, and <LOQ to 0.42 microg/l for 4'-OHD, 5-OHD, and 4'-OHDD, respectively, while median diclofenac concentrations ranged from 1.3 to 3.3 mug/l. The wide occurrence of its metabolites is highly relevant on account of their structural similarity and the toxicological properties of diclofenac and needs further examination of both toxicity and environmental concentrations of the metabolites.

Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies

In the aquatic environment, pharmaceuticals have been widely found. Among them, carbamazepine and diclofenac were detected at the highest frequency. To evaluate the worldwide environmental impacts of both drugs, their global consumption volumes are estimated, based on the dose per capita. The metabolites of these pharmaceuticals are also of environmental concerns, especially trans-10,11-dihydro-10,11- dihydroxycarbamazepine (CBZ-diol) which probably has a similar concentration in water bodies to that of its parent drug. The removal efficiencies and mechanisms of both drugs in the wastewater treatment plants (WWTPs) are discussed with the actual state of knowledge. The occurrences of both drugs are examined in various water bodies including WWTP effluents, surface waters, groundwater and drinking water. Their chemical, physical and pharmacological properties are also addressed in context, which can largely influence their environmental behaviors. The ecotoxicological studies of both drugs imply that they do not easily cause acute toxic effects at their environmental concentrations. However their chronic effects need cautious attention.

Biodegradation of acidic pharmaceuticals in bed sediments: insight from a laboratory experiment

Pharmaceutical residues are commonly detected micropollutants in the aquatic environment. Biodegradation in sediments is a potentially significant removal process for these compounds in rivers which is constrained by the transfer of water and solutes into the sediment. The aim of this study was to determine the combined effect of flow velocity and sediment dynamics and thus of water-sediment interactions on the attenuation of 6 acidic pharmaceuticals. We carried out experiments with river water and sediment in a bench-scale annular flume at two different hydraulic boundary conditions (flat sediment surface vs moving sediment). The effective biodegradation half-lives of 4 compounds (diclofenac, bezafibrate, ibuprofen, naproxen) were in the range of 2.5 to 18.6 days and were much shorter when the exchange of surface and pore water was fast. For gemfibrozil, a half-life of 10.5 d was determined in the experiment with moving sediment, whereas no degradation was observed with flat sediment bed. These findings can be attributed to the limited transfer of water and solutes into the sediment at low flow velocity and flat sediment bed which rapidly induced anaerobic conditions in the sediment. The only compound that was efficiently removed in deeper, anoxic sediment layers was naproxen. The calculated half-life distances in rivers ranged from 53 to 278 km. Our results indicate that it could be favorable to increase the rate of exchange between surface and pore water during river restoration to enhance the attenuation of organic micropollutants like acidic pharmaceuticals.

Oxidation of diclofenac with ozone in aqueous solution

Ozonation of diclofenac in aqueous solution in the presence and absence of an *OH scavenger, tertiary butanol (t-BuOH), was studied, and the most important reaction intermediates and products were identified. The second-order O3 rate constantwas determined by competition with buten-3-ol and was found to be 6.8 x 10(5) M(-1) s(-1) at 20 degrees C. From this high rate constant, it has been concluded that O3 must initially add on the amino nitrogen. Decomposition of the adduct results in the formation of O3*- (--> *OH) and aminyl radical precursors. A free *OH yield of 30% was estimated based on the HCHO yields generated upon reaction of *OH with 0.01 M t-BuOH. Almost all diclofenac reacted when the molar ratio of O3/diclofenac was approximately 5:1 in the presence of t-BuOH and approximately 8:1 in its absence. As primary reaction products (maximum yield), diclofenac-2,5-iminoquinone (32%), 5-hydroxydiclofenac (7%), and 2,6-dichloroaniline (19%) were detected with respect to reacted diclofenac in the presence of t-BuOH. These primary products degraded into secondary ones when the O3 dose was increased. In the *OH-mediated reaction (absence of t-BuOH) small yields of 5-hydroxydiclofenac (4.5%), diclofenac-2,5-iminoquinone (2.7%), and 2,6-dichloroaniline (6%) resulted. Practically all Cl- (95%) was released in the absence of t-BuOH but only about 45% in the presence of t-BuOH at an O3/diclofenac molar ratio of 10: 1. Based on the reaction products, mechanisms that may account for the high O3 consumption during ozonation of diclofenac are suggested. For technical applications, adequate supply of O3 is needed not only to eliminate diclofenac, but also for the degradation of its potentially toxic products like diclofenac-2,5-iminoquinone and 5-hydroxydiclofenac.

Assessing the concentrations of polar organic microcontaminants from point sources in the aquatic environment: measure or model?

To carry out meaningful ecotoxicity studies on novel polar organic microcontaminants, it is essential to know what concentrations wildlife may be exposed to. Traditionally these values were obtained by analytical chemistry, but in recent years GIS water quality models have been developed which may offer a quick and reliable way of getting the same information. Thus, two ways of obtaining basically the same information now exist, and an issue, therefore, arises as to which method is the most appropriate to use in which situation. To address this issue we have critically reviewed and compared measuring and modeling approaches for the determination of sewage effluent and river water concentrations of organic microcontaminants. Where model predictions and chemical measurements can be directly compared in sewage effluents, receiving waters, and across catchments, reported model mean values have all been within 1 order of magnitude of the measured values, with typically no more than a 3- or 4-fold difference. Interlaboratory chemical analysis of some organic microcontaminants in effluents in the challenging ng/L range have provided results which have varied from one another by a similar margin. No such comparison has been carried out yet for GIS water quality models to determine variation in predicted concentrations. As the level of ecotoxicological effects of many chemicals is often considerably higher than the reported measured or modeled values, such errors that might occur will often be of no consequence. But due to their extraordinary potency, much more accuracy is required with some natural and synthetic hormones. Significantly, modeling is no more complex to conduct when dealing with contaminants at ng/L compared with mg/L concentrations, but the same cannot be said for chemical analysis. A combination of modeling and measuring techniques will give the greatest confidence in risk assessment.

Using liquid chromatography-ion trap mass spectrometry to determine pharmaceutical residues in Taiwanese rivers and wastewaters

To establish their environmental concentrations and to support surface water protection programs, we have undertaken a preliminary study of the concentrations of selected acidic and neutral pharmaceutical residues (clofibric acid, ketoprofen, ibuprofen, diclofenac and carbamazepine) in Taiwanese river and wastewater samples. These pharmaceutical residues were extracted from the water samples through the Oasis HLB solid-phase extraction (SPE). The analytes were then identified and quantified using liquid chromatography-ion trap mass spectrometry with dual-polarity electrospray ionization in the product ion scan mode. The limits of quantification (LOQs) ranged between 0.5 and 20 ngl(-1) for 250 ml samples of water. We investigated the intra- and interbatch precision and accuracy at two levels of concentration. The selected analytes were detected at concentrations ranging from <0.5 to 960 ngl(-1) in wastewater treatment plant effluents and river water samples.

Sources of pharmaceutical pollution in the New York City Watershed

An investigation was carried out in the New York City Watershed for the presence of selected pharmaceuticals. In four seasonal sampling events between August 2003 and May 2004, surface water was collected from eight reservoir keypoints and effluent was collected from four wastewater treatment plants. We evaluated the following twelve compounds: amoxicillin, atenolol, caffeine, carbamazepine, cephalexin, estrone, 17alpha-ethinylestradiol, 17beta-estradiol, ibuprofen, sulfamethoxazole, trimethoprim, and valproic acid. In the treated effluents, carbamazepine was detected most frequently (100%; concentration range: 22-551 ng/L), followed by atenolol (94%; ND - 14,200 ng/L), trimethoprim (83%; ND - 37,000 ng/L), ibuprofen (61%; ND - 14,600 ng/L), and caffeine (49%; ND - 37,200 ng/L), while estrone was detected once (56 ng/L). In the reservoir keypoint samples, only ibuprofen (2.5%; ND - 932 ng/L) and caffeine (2.9%; ND - 177 ng/L) were detected. The other analytes were not detected in any sample. It is expected that investigation of other wastewater treatment plants in the New York City Watershed would show that their effluents are also a potential source of pharmaceuticals, but that these pharmaceuticals are unlikely to be detected in the Watershed's surface waters.

Occurrence and fate of antibiotics in the Seine River in various hydrological conditions

Occurrence and fate of 17 antibiotics were investigated in the aqueous phase of river water under different hydrological conditions at 5 sampling locations in the Seine River inner estuary. The target analytes belonged to 4 groups: quinolones, sulfonamides, nitro-imidazoles and diaminopyrimidines. This six-month survey (from January to June 2006) showed that different compounds were occurring at individual concentrations reaching 544 ng L(-)(1) (sulfamethoxazole). All 17 compounds were detected at least once in the survey. Sulfamethoxazole was detected in every sample, and showed the highest concentrations. Norfloxacin and flumequine were found to be the most ubiquitous quinolones, with detection frequencies of 33 and 75% respectively at the most contaminated site (Poses). Investigations concerning the origins of this contamination were made by means of a longitudinal profile along the Seine River between Paris and Poses. It showed large inputs of norfloxacin, ofloxacin, trimethoprim and sulfamethoxazole from wastewater treatment plants, with an increase in norfloxacin and sulfamethoxazole concentrations of 84% and 70% respectively, both reaching 155 ng L(-)(1) in the river, downstream from a wastewater outlet. The detected compounds showed different dissipation patterns and behaviours under different hydrological conditions. Higher inputs of norfloxacin were found in low flow conditions, which were rapidly attenuated along the stream. In contrast, sulfamethoxazole inputs were increasing in high flow conditions, and dissipation of this compound was found to be slow. Similar behaviour was observed for the synergist trimethoprim. Flumequine was also frequently detected and its input increased during flood events.

Effects of pharmaceutically active compounds on a mixed microbial community originating from a municipal wastewater treatment plant

The growth and composition of microorganisms found in a municipal wastewater treatment plant were investigated in the presence of four pharmaceutically active compounds (PhACs) [ketoprofen, naproxen, carbamazepine, and clofibric acid] in batch reactors at varying organic loadings. Overall, the data suggest that microbial growth inhibition was correlated to organic loading rather than PhAC concentration. Significant inhibition ranging from 34 to 43% was observed under the lowest organic loading for all PhACs other than clofibric acid. No inhibition was observed at the highest organic loading. Higher microbial inhibition was not observed with increased PhAC concentration for a given organic loading. These results indicatethatthe presence of PhAC may affect microbial growth especially under lower organic loading conditions. Further validation is required with additional PhACs, organic substrates, and a wider loading range. In addition, significant microbial shifts were observed in the presence of ketoprofen and naproxen. These data suggest that, in addition to their effect on overall microbial growth, PhACs may affect the microbial ecology and additional research should be carried out to identify PhACs that have the potential of affecting ecologically important microorganisms in wastewater treatment processes and aquatic environments in general.

Photocatalytic degradation of non-steroidal anti-inflammatory drugs with TiO2 and simulated solar irradiation

The aim of this work is to evaluate and compare the degradation achieved for three non-steroidal anti-inflammatory drugs (NSAIDs) by heterogeneous TiO2 photocatalytic means in aqueous solution at laboratory scale. The selected pharmaceutical compounds were diclofenac (DCF), naproxen (NPX) and ibuprofen (IBP). These compounds were used in their sodium salt chemical form. Previous experiments (adsorption, photolysis and thermodegradation) were developed to evaluate non-catalytic degradation for each NSAID. Photocatalytic experiments were carried out in a Xe-lamp reactor in order to study the influences of different operational conditions (catalyst load, temperature and dissolved oxygen concentration). These results showed that the optimum amount of TiO2, to achieve maximum degradation, of IBP was 1g/L. In contrast, the maximum degradation for DCF or NPX was observed at a TiO2 loading of 0.1g/L. Temperature had a significant effect only for NPX degradation, achieving almost 99% phototransformation. No significant differences were observed for DCF and IBP at 20, 30 and 40 degrees C. Dissolved oxygen concentration was an important parameter to increase the degradation for NPX and IBP. However, it was observed that its rate of mineralization did not increase. Intermediate metabolites were detected in all cases. Hydroxyl metabolites were the most important residual compounds after the photocatalytic treatment of IBP. The inhibition percentage of bioluminescence from Vibro fischeri--as a toxicity parameter--increased during the irradiation time due to the residual concentration of the hydroxyl metabolites generated. However, after 120 min, in experiments with 40 mg/L of dissolved oxygen, a decrease of the % inhibition was observed. Only photocatalytic treatment of IBP drives to a satisfactory biodegradability index BOD5/COD (between 0.16 and 0.42) and, only in this case, a post-biological treatment could be suggested.

Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia

The discovery that natural and synthetic chemicals, in the form of excreted hormones and pharmaceuticals, as well as a vast array of compounds with domestic and industrial applications, can enter the environment via wastewater treatment plants and cause a wide variety of environmental and health problems even at very low concentrations, suggests the need for improvement of water recycling. Three Australian wastewater recycling schemes, two of which employ reverse osmosis (RO) technology, the other applying ozonation and biological activated carbon filtration, have been studied for their ability to remove trace organic contaminants including 11 pharmaceutically active compounds and two non-steroidal estrogenic compounds. Contaminant concentrations were determined using a sensitive analytical method comprising solid phase extraction, derivatization and GC with MS using selected ion monitoring. In raw wastewater, concentrations of analgesics and non-steroidal anti-inflammatory medications were comparable to those found in wastewaters around the world. Remarkably, removal efficiencies for the three schemes were superior to literature values and RO was responsible for the greatest proportion of contaminant removal. The ability of RO membranes to concentrate many of the compounds was demonstrated and highlights the need for continued research into monitoring wastewater treatment, concentrate disposal, improved water recycling schemes and ultimately, safer water and a cleaner environment.

Application of Porous Membrane-Protected Micro-Solid-Phase Extraction Combined with HPLC for the Analysis of Acidic Drugs in Wastewater

This report describes the use of a porous membrane-protected micro-solid-phase extraction (micro-SPE) procedure to extract acidic drugs from wastewater that are then determined by high-performance liquid chromatography with ultraviolet detection. The micro-SPE device consists of C18 sorbent held within a membrane envelope made of polypropylene. Ketoprofen and ibuprofen were selected as model compounds, and extraction parameters were optimized. Correlation coefficients of 0.9980 and 0.9953 were obtained for ketoprofen and ibuprofen, respectively, across a concentration range of 1-250 microg/L. Relative extraction recoveries were between 94 and 112%. The relative standard deviation of the analytical method ranged between 2 and 10%, respectively. The method detection limits for these target analytes in wastewater ranged from 0.03 to 0.08 microg/L. When compared to conventional solid-phase extraction (SPE), this new method showed better detection limits with good reproducibility. The results shows that this micro-SPE technique is a feasible alternative to multistep SPE for the extraction of analytes in complex samples.

Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant

The occurrence of four beta blockers, one antiepileptic drug, one lipid regulator, four anti-inflammatories, and three fluoroquinolones was studied in a river receiving sewage effluents. All compounds but two of the fluoroquinolones were observed in the water above their limit of quantification concentrations. The highest concentrations (up to 107 ng L(-1)) of the compounds were measured during the winter months. The river water was passed to a pilot-scale drinking water treatment plant, and the elimination of the pharmaceuticals was followed during the treatment. The processes applied by the plant consisted of ferric salt coagulation, rapid sand filtration, ozonation, two-stage granular activated carbon filtration (GAC), and UV disinfection. Following the coagulation, sedimentation, and rapid sand filtration, the studied pharmaceuticals were found to be eliminated only by an average of 13%. An efficient elimination was found to take place during ozonation at an ozone dose of about 1 mg L(-1) (i.e., 0.2-0.4 mg of O3/ mg of TOC). Following this treatment, the concentrations of the pharmaceuticals dropped to below the quantification limits with the exception of ciprofloxacin. Atenolol, sotalol, and ciprofloxacin, the most hydrophilic of the studied pharmaceuticals, were not fully eliminated during the GAC filtrations. All in all, the treatment train was found to very effectively eliminate the pharmaceuticals from the rawwater. The only compound that was found to pass almost unaffected through all the treatment steps was ciprofloxacin.

Toxic and genotoxic impact of fibrates and their photoproducts on non-target organisms

Lipid regulators have been detected in effluents from sewage treatment plants and surface waters from humans via excretion. This study was designed to assess the ecotoxicity of fibrates, lipid regulating agents. The following compounds were investigated: Bezafibrate, Fenofibrate and Gemfibrozil and their derivatives obtained by solar simulator irradiation. Bioassays were performed on bacteria, algae, rotifers and microcrustaceans to assess acute and chronic toxicity, while SOS Chromotest and Ames test were utilized to detect the genotoxic potential of the investigated compounds. The photoproducts were identified by their physical features and for the first risk evaluation, the environmental impact of parental compounds was calculated by Measured Environmental Concentrations (MEC) using the available data from the literature regarding drug occurrence in the aquatic environment and the Predicted No Effect Concentrations (PNEC) based on our toxicity data. The results showed that acute toxicity was in the order of dozens of mg/L for all the trophic levels utilized in bioassays (bacteria, rotifers, crustaceans). Chronic exposure to these compounds caused inhibition of growth population on rotifers and crustaceans while the algae seemed to be slightly affected by this class of pharmaceuticals. Genotoxic and mutagenic effects were especially found for the Gemfibrozil photoproduct suggesting that also byproducts have to be considered in the environmental risk of drugs.

Synthesis and application of a carbamazepine-imprinted polymer for solid-phase extraction from urine and wastewater

A molecularly imprinted polymer (MIP) designed to enable the selective extraction of carbamazepine (CBZ) from effluent wastewater and urine samples has been synthesised using a non-covalent molecular imprinting approach. The MIP was evaluated chromatographically in the first instance and its affinity for CBZ also confirmed by solid-phase extraction (SPE). The optimal conditions for SPE consisted of conditioning of the cartridge using acidified water purified from a Milli-Q system, loading of the sample under basic aqueous conditions, clean-up using acetonitrile and elution with methanol. The attractive molecular recognition properties of the MIP gave rise to good CBZ recoveries (80%) when 100 mL of effluent water spiked with 1 microg L(-1) was percolated through the polymer. For urine samples, 2 mL samples spiked with 2.5 microg L(-1) CBZ were extracted with a recovery of 65%. For urine, the linear range was 0.05-24 mg L(-1), the limit of detection was 25 microg L(-1) and precision, expressed as relative standard deviation at 0.5 mg L(-1) (n=3), was 3.1% and 12.6% for repeatability and reproducibility between days, respectively.

Photodegradation of norfloxacin in aqueous suspensions of titanium dioxide

The photocatalytic degradation of an antibiotic norfloxacin [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid, 1], has been investigated in aqueous suspensions of titanium dioxide (TiO(2)) under a variety of conditions. The degradation was studied by monitoring the change in substrate concentration employing UV spectroscopic analysis technique and depletion in total organic carbon (TOC) content as a function of irradiation time. The degradation kinetics were investigated under different conditions such as different types of TiO(2), pH (ranging from 4 to 11), catalyst concentration (0.5-3gL(-1)), substrate concentration (0.15-0.5mM) and in the presence of electron acceptor such as hydrogen peroxide (H(2)O(2), 10mM) besides molecular oxygen. Semiconductor titanium dioxide (Degussa P25) was found to be more efficient as compared with other photocatalysts.

Simultaneous determination of various pharmaceutical compounds in water by solid-phase extraction–liquid chromatography–tandem mass spectrometry

A solid-phase extraction (SPE) followed by liquid chromatography-electrospray ionisation tandem mass spectrometry (LC-ESI-MS-MS) method was developed and validated for simultaneous analysis of 11 pharmaceutical residues (propranolol, sulfamethoxazole, meberverine, thioridazine, carbamazepine, tamoxifen, mecoprop, indomethacine, diclofenac, meclofenamic acid and monensin) in environmental water samples. The collision energy chosen for the multiple reaction monitoring (MRM) experiment was optimised. A number of parameters that may affect the recovery of the pharmaceuticals, such as the type of SPE cartridges, eluents, as well as water properties including pH value, salinity and concentration of colloid and surfactant were investigated. It is shown that the Oasis HLB SPE cartridge produced the best recoveries of the target pharmaceuticals while methanol was efficient in eluting pharmaceuticals from SPE cartridges. The recovery of some target compounds was enhanced with increasing salinity, but reduced by increasing pH value, and unaffected by surfactant concentration (0-10 microg/l). The recovery of most compounds was slightly increased by the presence of colloids (0-10 mg/l), which however caused a reduction in recovery for sulfamethoxazole and meberverine. The optimised method was further verified by performing spiking experiments in river water and seawater matrices, with good recovery and reproducibility for all except two compounds. The established method was successfully applied to environmental water samples from East Sussex, UK, for the determination of the target pharmaceuticals.

Pharmaceutical determination in surface and wastewaters using high-performance liquid chromatography-(electrospray)-mass spectrometry

A method was developed to determine 11 pharmaceutical compounds in water samples. The method uses SPE and HPLC coupled to MS (LC/MS) using ESI in both positive and negative modes. Three different sorbents were compared for the extraction of analytes from river and sewage treatment plant (STP) waters and OASIS HLB provided the best results. For the solid-phase extraction of 500 mL of river water samples, the recoveries were between 41 and 101% with the exception of acetaminophen, salicylic acid and naproxen. The LODs were between 3 and 5 ng/L for all the compounds, except naproxen which had an LOD of 15 ng/L. Acetaminophen, caffeine, carbamazepine, bezafibrate and ibuprofen were found in three of the tested river samples at ng/L levels and among them, the highest values were for caffeine and bezafibrate with 305 and 363 ng/L, respectively. For the influent and effluent water samples of the STP, volumes of 100 and 250 mL were used, respectively, to obtain acceptable recoveries. All the compounds showed recoveries between 33 and 91% for effluent samples and 33-72% for influent samples, with the exception of acetaminophen, salicylic acid and bezafibrate, which had lower recoveries. The method developed enabled pharmaceuticals in the influent and effluent sewage waters to be determined in five campaigns carried out between February 2004 and June 2005. Several pharmaceuticals were found in the influent samples: for instance, maximum concentrations of ibuprofen and caffeine were 6 and 40 microg/L, respectively.

Analytical development for analysis of pharmaceuticals in water samples by SPE and GC-MS

An analytical procedure involving solid-phase extraction (SPE) and gas chromatography-mass spectrometry (GC-MS) has been developed for determination of pharmaceutical compounds (aspirin, caffeine, carbamazepine, diclofenac, ketoprofen, naproxen, ibuprofen, clofibrate, clofibric acid, and gemfibrozil) in a variety of aqueous samples (wastewater and surface water). After filtration, samples were extracted and concentrated using C(18) or HLB cartridges, depending on the type of compound. Sample storage conditions were checked and optimized to ensure preservation of the pharmaceutical substance, taking into consideration environmental sampling conditions. For most of the pharmaceuticals monitored, recovery was in the range 53 to 99% and the variability was below 15% for the complete procedure, with limits of detection ranging from 0.4 to 2.5 ng L(-1), depending on the compound. The methods were successfully applied to monitoring of pharmaceutical contamination of the Seine estuary. Concentrations varied from several dozens of nanograms per liter for surface waters to several hundreds of nanograms per liter for wastewaters.

Elimination of pharmaceuticals in sewage treatment plants in Finland

The occurrence of eight pharmaceuticals (beta-blockers: acebutolol, atenolol, metoprolol and sotalol; antiepileptic: carbamazepine; fluoroquinolone antibiotics: ciprofloxacin, norfloxacin, ofloxacin) were assessed in the raw and treated sewage of 12 sewage treatment plants (STPs) in Finland. The average concentrations in the raw and treated sewage ranged from 100 to 1060 ng L(-1) and from <24 to 755 ng L(-1), respectively. The average daily loads ranged from 36 to 405 mg/1000 inh and from 2 to 302 mg/1000 inh, respectively. In the treatment plants, fluoroquinolones were eliminated by >80%. Carbamazepine was not eliminated during the treatment and in fact even higher concentrations were frequently found in the treated than in the raw sewages. The increase in concentration was shown to be most likely due to enzymatic cleavage of the glucuronic conjugate of carbamazepine and release of the parent compound in the treatment plant. The beta-blockers were eliminated in average by less than 65% and the elimination varied greatly between the treatment plants. Especially the dilution of raw sewage by rainwater and a consequent decrease in the hydraulic retention time of a treatment plant was found to deteriorate the elimination of the beta-blockers. The work shows that especially carbamazepine and the beta-blockers may reach the recipient waters and there is a need to enhance their elimination in the sewage treatment plants. In this attempt, a denitrifying biofilter as a tertiary treatment could be of minor importance since in this study it did not result in further elimination of the target compounds.

Identifying model pollutants to investigate biodegradation of hazardous XOCs in WWTPs

Xenobiotic organic compounds (XOCs) in wastewater treatment plant (WWTP) effluents might cause toxic effects in ecosystems. Several investigations have emphasized biodegradation as an important removal mechanism to reduce pollution with XOCs from WWTP effluents. The aim of the study was to design a screening tool to identify and select hazardous model pollutants for the further investigation of biodegradation in WWTPs. The screening tool consists of three criteria: The XOC is present in WWTP effluents, the XOC constitutes an intolerable risk in drinking water or the environment, and the XOC is expected to be biodegradable in WWTPs. The screening tool was tested on bisphenol A (BPA), carbamazepine (CBZ), di(2ethylhexyl)-phthalate (DEHP), 17beta-estradiol (E2), estrone (E1), 17alpha-ethinyloetradiol (EE2), ibuprofen, naproxen, nonylphenol (NP), and octylphenol (OP). BPA, DEHP, E2, E1, EE2, and NP passed all criteria in the screening tool and were selected as model pollutants. OP did not pass the filter and was rejected as model pollutant. CBZ, ibuprofen, and naproxen were not finally evaluated due to insufficient data.

Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine

Fluoxetine, a selective serotonin reuptake inhibitor antidepressant and high-prescription-volume drug, is excreted unchanged or as a glucuronide from the human organism. Little is known about its fate in sewage treatment plants. Effects of fluoxetine on life-cycle parameters of the midge Chironomus riparius, especially development (mean emergence time), emergence, sex ratio, and fecundity, were assessed, as well as effects on reproduction of the oligochaete Lumbriculus variegatus and of the freshwater mudsnail Potamopyrgus antipodarum. Due to the moderate lipophilic properties of the compound with a log P (OW) of 4.05, C. riparius and L. variegatus were exposed to fluoxetine via spiked artificial sediment at a nominal concentration range between 0.15 and 5.86 mg/kg (dry weight). Additionally, a test was performed exposing P. antipodarum via water in a nominal concentration range between 0.64 and 400 mug/L. As endpoints, emergence rate and timing, sex ratio, clutch numbers and clutch size of the midges, the number of worms in the oligochaete test, as well as the number of embryos in the snail test were monitored. For C. riparius, no clear substance-related effects were observed; for L. variegatus, the results indicated a slight increase in reproduction, which was statistically significant at nominal fluoxetine concentrations of 0.94 and 2.34 mg/kg. In P. antipodarum, the antidepressant reduced reproduction significantly. No observed effect concentration (NOEC) and 10% effect concentration (EC(10)) were determined to be 0.47 and 0.81 mug/L, respectively, based on measured fluoxetine concentrations in water. These low values indicate that P. antipodarum and possibly other aquatic mollusks are sensitive to fluoxetine and that the drug might pose a risk to gastropod populations in the field.

Occurrence patterns of pharmaceuticals in water and wastewater environments

The occurrence of pharmaceuticals and their metabolites and transformation products in the environment is becoming a matter of concern, because these compounds, which may have adverse effects on living organisms, are extensively and increasingly used in human and veterinary medicine and are released continuously into the environment. A variety of pharmaceuticals have been detected in many environmental samples worldwide. Their occurrence has been reported in sewage-treatment-plant effluents, surface water, seawater, groundwater, soil, sediment and fish. This paper provides an overview of recent scientific research on the sources, occurrence, and fate of pharmaceuticals in water and wastewater.

Recently developed GC/MS and LC/MS methods for determining NSAIDs in water samples

Pharmaceuticals have become major targets in environmental chemistry due to their presence in aquatic environments (following incomplete removal in wastewater treatment or point-source contaminations), threat to drinking water sources and concern about their possible effects to wildlife and humans. Recently several methods have been developed for the determination of drugs and their metabolites in the lower nanogram per litre range, most of them using solid-phase extraction (SPE) or solid-phase microextraction (SPME), derivatisation and finally gas chromatography mass spectrometry (GC-MS), gas chromatography tandem mass spectrometry (GC-MS/MS) and liquid chromatography electrospray tandem mass spectrometry (LC-ES/MS/MS). Due to the elevated polarity of non-steroidal anti-inflamatory drugs (NSAIDs), analytical techniques based on either liquid chromatography coupled to mass spectrometry (LC-MS) and gas chromatography coupled to mass spectrometry (GC-MS) after a previous derivatisation step are essential. The most advanced aspects of current GC-MS, GC-MS/MS and LC-MS/MS methodologies for NSAID analysis are presented.

Polar herbicides, pharmaceutical products, perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and nonylphenol and its carboxylates and ethoxylates in surface and tap waters around Lake Maggiore in Northern Italy

A survey of contamination of surface and drinking waters around Lake Maggiore in Northern Italy with polar anthropogenic environmental pollutants has been conducted. The target analytes were polar herbicides, pharmaceuticals (including antibiotics), steroid estrogens, perfluorooctanesulfonate (PFOS), perfluoroalkyl carboxylates (including perfluorooctanoate PFOA), nonylphenol and its carboxylates and ethoxylates (NPEO surfactants), and triclosan, a bactericide used in personal-care products. Analysis of water samples was performed by solid-phase extraction (SPE) then liquid chromatography-triple-quadrupole (tandem) mass spectrometry (LC-MS-MS). By extraction of 1-L water samples and concentration of the extract to 100 microL, method detection limits (MDLs) as low as 0.05-0.1 ng L(-1) were achieved for most compounds. Lake-water samples from seven different locations in the Southern part of Lake Maggiore and eleven samples from different tributary rivers and creeks were investigated. Rain water was also analyzed to investigate atmospheric input of the contaminants. Compounds regularly detected at very low concentrations in the lake water included: caffeine (max. concentration 124 ng L(-1)), the herbicides terbutylazine (7 ng L(-1)), atrazine (5 ng L(-1)), simazine (16 ng L(-1)), diuron (11 ng L(-1)), and atrazine-desethyl (11 ng L(-1)), the pharmaceuticals carbamazepine (9 ng L(-1)), sulfamethoxazole (10 ng L(-1)), gemfibrozil (1.7 ng L(-1)), and benzafibrate (1.2 ng L(-1)), the surfactant metabolite nonylphenol (15 ng L(-1)), its carboxylates (NPE(1)C 120 ng L(-1), NPE(2)C 7 ng L(-1), NPE(3)C 15 ng L(-1)) and ethoxylates (NPE( n )Os, n = 3-17; 300 ng L(-1)), perfluorinated surfactants (PFOS 9 ng L(-1), PFOA 3 ng L(-1)), and estrone (0.4 ng L(-1)). Levels of these compounds in drinking water produced from Lake Maggiore were almost identical with those found in the lake itself, revealing the poor performance of sand filtration and chlorination applied by the local waterworks.

Degradation of clofibric acid in acidic aqueous medium by electro-Fenton and photoelectro-Fenton

Acidic aqueous solutions of clofibric acid (2-(4-chlorophenoxy)-2-methylpropionic acid), the bioactive metabolite of various lipid-regulating drugs, have been degraded by indirect electrooxidation methods such as electro-Fenton and photoelectro-Fenton with Fe(2+) as catalyst using an undivided electrolytic cell with a Pt anode and an O(2)-diffusion cathode able to electrogenerate H(2)O(2). At pH 3.0 about 80% of mineralization is achieved with the electro-Fenton method due to the efficient production of oxidant hydroxyl radical from Fenton's reaction between Fe(2+) and H(2)O(2), but stable Fe(3+) complexes are formed. The photoelectro-Fenton method favors the photodecomposition of these species under UVA irradiation, reaching more than 96% of decontamination. The mineralization current efficiency increases with rising metabolite concentration up to saturation and with decreasing current density. The photoelectro-Fenton method is then viable for treating acidic wastewaters containing this pollutant. Comparative degradation by anodic oxidation (without Fe(2+)) yields poor decontamination. Chloride ion is released during all degradation processes. The decay kinetics of clofibric acid always follows a pseudo-first-order reaction, with a similar rate constant in electro-Fenton and photoelectro-Fenton that increases with rising current density, but decreases at greater metabolite concentration. 4-Chlorophenol, 4-chlorocatechol, 4-chlororesorcinol, hydroquinone, p-benzoquinone and 1,2,4-benzenetriol, along with carboxylic acids such as 2-hydroxyisobutyric, tartronic, maleic, fumaric, formic and oxalic, are detected as intermediates. The ultimate product is oxalic acid, which forms very stable Fe(3+)-oxalato complexes under electro-Fenton conditions. These complexes are efficiently photodecarboxylated in photoelectro-Fenton under the action of UVA light.

Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi river water, in New Orleans, Louisiana, USA

An effective analytical method for simultaneously determining 16 polycyclic aromatic hydrocarbons (PAHs), 28 polychlorinated biphenyl (PCBs), and 12 pharmaceuticals and personal care products (PPCPs) has been developed to measure their concentrations in the Mississippi river waters in New Orleans, Louisiana, USA. The method involves the simultaneous extraction of the selected PAHs, PCBs, and PPCPs, from the aqueous phase by solid phase extraction using two-layer disks consisting of C(18) and SDB-XC, and collection of suspended solid in water samples by 0.2-0.6 microm filter in a single step. Target compounds adsorbed on the extraction disks were eluted with methanol, acetone, and dichloromethane. The suspended particles retained by the filter were sonically extracted using the same solvents. GC/MS was used for quantification of PAHs and PCBs directly and of PPCPs after derivatization. The analytical method was used in a 6-month field study of the Mississippi river water for contamination by PAHs, PCBs, and PPCPs and the following concentrations (ng/l) have been obtained: clofibric acid (3.2-26.7), ibuprofen (0-34.0), acetaminophen (24.7-65.2), caffeine (0-38.0), naproxen (0-135.2), triclosan (8.8-26.3), bisphenol A (0-147.2), carbamazepine (42.9-113.7), estrone (0-4.7), 17beta-estradiol (0-4.5), total PAHs (62.9-144.7), and total PCBs (22.2-163.4).

Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast

A one-year monitoring study was performed to evaluate the occurrence, persistence and fate of a group of 14 organic compounds in a sewage treatment plant (STP) located in the south of Spain. These results are part of a more extensive study, financed by the Spanish Ministry of Research with the aim to evaluate the traceability of new pollutants on the Mediterranean coast and to determine the removal efficiency of sewage treatment plants (STP) for these pollutants. The compounds which have been analyzed include pharmaceuticals of various therapeutic categories (ibuprofen, acetaminophen, dipyrone, diclofenac, carbamazepine and codeine), pesticides (chlorfenvinfos and permethrin), caffeine, triclosan, bisphenol A and three of their more relevant metabolites (1,7-dimethylxanthine, carbamazepine 10,11-epoxide and 2,7/2,8-dichlorodibenzo-p-dioxin). An SPE/GC-MS multi-residue analytical method was developed and validated to facilitate simultaneous determination of these compounds in both influent and effluent wastewater. The method provided mean recoveries higher than 75%, with the exception of 2,7/2,8-dichlorodibenzo-p-dioxin, dipyrone and permethrin which exhibited recoveries lower than 22%. The overall variability of the method was below 14%. The method detection limit (LOD) was between 1 and 100 ng l(-1) and precision, which was calculated as relative standard deviation (RSD), ranged from 1.8% to 11.2%. The application of the proposed method has allowed the identification of all the target compounds at mean concentrations which ranged from 0.12 to 134 microg l(-1) in the influent and from 0.09 to 18.0 microg l(-1) in the effluent. The removal efficiencies of the STP for these compounds varied from 20% (carbamazepine) to 99% (acetaminophen), but in all cases resulted insufficient in order to avoid their presence in treated water and subsequently in the environment.

Benzotriazole and tolyltriazole as aquatic contaminants. 1. Input and occurrence in rivers and lakes

The complexing agents benzotriazole (BT) and tolyltriazole (TT) are not only widely applied as anticorrosives, e.g., in aircraft deicer and anti-icer fluid (ADAF), but they are also used for so-called silver protection in dishwasher detergents. Due to their low biodegradability and limited sorption tendency, BT and TT are only partly removed in wastewater treatment. Residual concentrations of BT and TT were determined in ambient surface waters in Switzerland including 7 rivers which have distinct water flows and receive treated wastewater effluents at various dilution ratios. A maximum BT concentration of 6.3 microg/L was found in the Glatt River, and a maximum mass flow of 277 kg BT per week was observed in the Rhine River. In most cases, TT was about a factor 5-10 less abundant. During winter 2003/4, BT mass flows at 2 locations in the lower stretch of the Glatt River clearly indicated the input from nearby Zurich airport, where BT was applied as an anticorrosive ADAF component. BT concentrations measured in the three lakes Greifensee, Lake Zurich, and Lake Geneva were approximately 1.2, 0.1-0.4, and 0.2 microg/L, respectively. The observed environmental occurrences indicate that BT and TT are ubiquitous contaminants in the aquatic environment and that they belong to the most abundant individual water pollutants.